2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
152
Breast Neoplasms
40
Prostatic Neoplasms
31
Insulin Resistance
30
Obesity
23
Neoplasms
15
Endometrial Neoplasms
15
Pancreatic Neoplasms
14
Infertility
14
Colorectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
12
Anovulation
10
Lung Neoplasms
9
Neoplasm Metastasis
8
Hyperandrogenism
8
Glioblastoma
8
Diabetes Mellitus
8
Squamous Cell Carcinoma of Head and Neck
7
Metabolic Syndrome
7
Melanoma
7
Rectal Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Head and Neck Neoplasms
5
Brain Neoplasms
5
Adenocarcinoma
5
Weight Loss
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Interventions
Indocyanine Green
7
Lymph Node Excision
6
Surgical Procedures, Operative
5
Radiotherapy, Intensity-Modulated
4
Radiotherapy
4
Radiosurgery
4
Magnetic Resonance Spectroscopy
4
Cisplatin
4
Specimen Handling
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
Chemotherapy, Adjuvant
2
Chemoradiotherapy
2
Artificial Intelligence
2
tislelizumab
1
sarcolipin
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
lncRNA LNMAT1, human
1
gewf solution
1
fluoroazomycin arabinoside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Metformin
×
Clear all
NCT04947020
2025-02-25
BARO
Jagiellonian University
Completed
2,443 enrolled